NSTM Logo.png
  • Investments

    • NewStem
    • Netco Partners
  • Technology

  • Leadership

  • News

  • Investor Relations

  • More

    Use tab to navigate through the menu items.

    In The Press

    • Apr 11

    NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary

    • Feb 15

    NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset

    • Sep 28, 2021

    NovelStem Files Preliminary Financial Statements in Compliance with SEC Rule 15c2-11...

    • Sep 20, 2021

    NovelStem Announces NewStem, Ltd. was Selected by Illumina for its Global Illumina Accelerator

    • Dec 1, 2020

    NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing...

    • Apr 21, 2020

    NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform...

    • Dec 16, 2019

    NovelStem Provides Shareholder Update

    • May 8, 2019

    NovelStem Provides Shareholder Update

    • Sep 25, 2018

    Hollywood Media Changes Name and Stock Symbol to Novel Stem International Corp. and “NSTM”...

    • Jul 16, 2018

    Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer...

    COMPANY HEADQUARTERS

    2255 Glades Road, Suite 221A

    Boca Raton, FL 33431

    NOVELSTEM CONTACT

    Phone: (410) 654-3315
    Email: jloeb@leaptidecapital.com

    INVESTOR RELATIONS CONTACT

    William Jones: (267) 987-2082
    David Collins: (212) 924-9800

    Email: nstm@catalyst-ir.com